NCT00002308已完成不适用
A Randomized Blinded Evaluation of Two Doses of Stavudine (2',3'-Didehydro-2',3'-Dideoxythymidine; d4T) to Make Treatment Available to Severely Immunocompromised Patients With HIV Infection Who Have Failed or Are Intolerant of Alternative Antiretroviral Therapy
Bristol-Myers Squibb2 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia ComplexAIDS Dementia ComplexHIV InfectionsNCT00002246Bristol-Myers Squibb20
已完成
2 期
Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected PatientsHIV InfectionsNCT00082498National Institute of Allergy and Infectious Diseases (NIAID)119
已完成
2 期
A Study of Viracept in HIV-Positive WomenHIV InfectionsNCT00002171Agouron Pharmaceuticals
已完成
不适用
A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.HIV InfectionsNCT00002349Bristol-Myers Squibb40
已完成
不适用
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsHIV InfectionsNCT00002307Bristol-Myers Squibb